About this site

The McGuireWoods Healthcare Private Equity Team previously published a multi-part series highlighting some of the more active private equity investors in the healthcare space. Since the original publication, we have seen even more PE investors turn toward healthcare investments, new healthcare-focused funds form, and healthcare PE deal activity continue at a staggering pace. Thus, we have decided to launch this site to highlight investors in a more current format, as part of our ongoing service to the healthcare private equity community. These investors, listed purely in alphabetical order, are funds that primarily focus on growth-stage, buyout and platform funding transactions. The sheer number of investors is a real testament to investors’ views of healthcare as a solid investment play.

Provident Healthcare Partners

Formed in 1998, Provident seeks investments in middle market healthcare companies. With offices in Boston and Los Angeles, the firm is the healthcare investment banking division of Provident Corporate Finance. Companies in its portfolio include BioDirection, a medical device company developing point-of-care products for the diagnosis of concussion and other traumatic brain injury. Read more about Provident at www.providentcapitalpartners.com

Pulse Equity Partners

Founded in 2010, Pulse pursues growth equity investments and buy-and-build strategies within three focus areas: healthcare, healthy lifestyles and nutrition. Based in New York, the firm prefers to make more substantial investments from a dollars perspective. Companies in its portfolio include Prospira PainCare, a provider of multidisciplinary pain management services; In-Shape Health Clubs, which owns and operates health clubs in California; and PhysicianOne Urgent Care, a provider of urgent care for non life-threatening medical conditions in Connecticut. Read more about Pulse at www.pulsequity.com

Regal Healthcare Capital Partners

Founded in 2018, Regal focuses exclusively on lower middle market healthcare services companies. Based in New York, the firm targets equity investments of $10 million to $30 million in companies with EBITDA of $2 million to $7 million. Companies in its portfolio include Extend Fertility, a fertility services company and one of the largest providers of cryopreservation; Emergency Care Partners, a national outsourced emergency room management business providing services to more than 25 hospitals across the country; and The Dermatology Specialists, a branded retail dermatology practice providing medical, surgical, and cosmetic dermatology services. Read more about Regal at www.regalhcp.com

Revelstoke Capital Partners

Founded in 2013, Revelstoke focuses on investing in the healthcare and related business services sectors. Based in Denver, the firm typically invests between $10 million and $250 million. Companies in its portfolio include a management company formed in partnership with Beacon Orthopaedics & Sports Medicine; a multi-physician practice providing orthopedic care to the Cincinnati community; CEI Vision Partners, an ophthalmology services organization formed in partnership with Cincinnati Eye Institute, the largest ophthalmology organization in its region; and Datalink Software, a provider of integrated population health management applications. Read more about Revelstoke at www.revelstokecp.com

Riata Capital Group

Founded in 2014, Riata pursues control and minority equity investments in middle market companies in healthcare and other sectors. Based out of Dallas, the firm is flexible in its investment size. Within healthcare, Riata pursues investments in the provider services industry and companies that live in the healthcare sector but do not have direct reimbursement risk. Healthcare companies in its portfolio include Smile Source, a network of independent dental practices in the United States. Read more about Riata at www.riatacapital.com

Ridgemont Equity Partners

Founded in 1993, Ridgemont is focused on investing in middle market companies to secure majority ownership or be the lead minority investor. Based in Charlotte, N.C., the firm prefers to make more substantial investments from a dollars perspective in several sectors, including healthcare. Companies in its healthcare portfolio include AccentHealth, a health education television network that delivers healthy programming to physicians’ offices; Allied 100, a provider of products and services to the automated external defibrillator marketplace; eviCore, a benefit management company; and AMN Healthcare Services, a provider of healthcare staffing and management services. Read more about Ridgemont at www.ridgemontep.com

River Cities Capital Funds

Founded in 1994, River Cities provides growth-stage equity financing, targeting companies generating $5 million and more in revenue. Based in Cincinnati, Ohio, the firm seeks to invest in healthcare and IT companies, with typical initial investments of $5 million to $15 million. Companies in its portfolio include OrthAlign, a medical device company that provides surgical navigation products for orthopedic procedures; TissueTech, a biotechnology company developing regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets; and Veran Medical Technologies, which develops minimally invasive therapies for interventional oncology procedures. Read more about River Cities at www.rccf.com

RiverGlade Capital

RiverGlade Capital is a private equity firm focused on control buyouts of growth-oriented, lower middle market healthcare companies. Through partnership with founder-owned, high-quality, differentiated businesses, RiverGlade strives to accelerate value, professionalize, and transform organizations into highly attractive strategic assets. Founded in 2017, RiverGlade’s Managing Partners have been investing together for more than two decades, and bring the resources, relationships, and validated methodologies to help scale exceptional healthcare companies. Read more about RiverGlade at www.rivergladecapital.com

The Riverside Company

Founded in 1988, Riverside focuses on acquiring and investing in growing businesses valued at up to $400 million. Co-headquartered in Cleveland and New York, the firm seeks control, non-control and growth equity investments across several industries, including healthcare. Riverside pursues companies across multiple segments of healthcare, including services, information technology, products and distribution. Companies in its healthcare portfolio include Naturally Slim, a digital counseling program for weight management; North American Dental Group, a provider of dental services in several states; HemaTerra Technologies, a provider of SaaS-based solutions for blood collection centers, plasma donation centers and hospitals; and Alter Pharma, a distributor of pharmaceuticals to wholesalers and hospitals. Read more about The Riverside Company at www.riversidecompany.com

Riverside Partners

Founded in 1988, Riverside Partners seeks investments in growing middle-market healthcare- and technology-oriented companies. Based in Boston, the firm typically invest in companies with revenues between $10 million and $100 million. Companies in its healthcare portfolio include BioAgilytix Labs, a contract bioanalytical laboratory specializing in large molecule biologic drugs; Enovate Medical, a designer and manufacturer of clinical workstations sold to hospitals; HealthDrive, a provider of multi-specialty, on-site healthcare services to residents of extended care facilities; and Dominion Diagnostics, a provider of clinical quantitative urine drug testing and medication monitoring. Read more about Riverside Partners at www.riversidepartners.com

Page 12 of 16